TriSalus Life Sciences Competitors and Similar CompaniesClear all
RenovoRx's competitors and similar companies include ChemoCentryx, Turning Point Therapeutics and NATCO Pharma.
 RenovoRx RenovoRx is a clinical-stage biopharmaceutical company focused on developing therapies for the local treatment of solid tumors. |  ChemoCentryx ChemoCentryx is a biopharmaceutical company commercializing and developing medications for inflammatory and autoimmune diseases and cancer. |  Turning Point Therapeutics Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases. |  NATCO Pharma NATCO Pharma is a company focused on research, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (API). | |
Founding Date | Founding Date 2012 | Founding Date 1997 | Founding Date 2013 | Founding Date 1981 |
Type | Type Public | Type Subsidiary | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations Los Altos, US HQ | Locations San Carlos, US HQ | Locations San Diego, US HQ | Locations Hyderabad, IN HQ Central Hope Town, IN Chennai, IN Hyderabad, IN Santola, IN Vijayapuri North, IN |
Employees | Employees 7 | Employees 51 | Employees 474% decrease | Employees 4,016 |
Financial | ||||
Revenue (est.) | Revenue (est.) $1.1m (FY, 2025) | Revenue (est.) $32.2m (FY, 2021) | Revenue (est.) $30.8m (FY, 2021) | Revenue (est.) ₹40.8b (FY, 2026) |
Cost of goods | Cost of goods $327k (FY, 2025) | Cost of goods $302k (FY, 2021) | Cost of goods N/A | Cost of goods ₹6.9b (FY, 2026) |
Gross profit | Gross profit $796k (FY, 2025) | Gross profit $31.9m (FY, 2021) | Gross profit N/A | Gross profit ₹36.9b (FY, 2026) |
Net income | Net income ($11.2m) (FY, 2025) | Net income ($131.8m) (FY, 2021) | Net income ($236.6m) (FY, 2021) | Net income ₹13.7b (FY, 2026) |
Funding | ||||
Total funding raised | Total funding raised $ 10.2m | Total funding raised $ 149.5m | Total funding raised $ 144.4m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
ChemoCentryx
HQ
San Carlos, US
ChemoCentryx is a biopharmaceutical company commercializing and developing medications for inflammatory and autoimmune diseases and cancer.
View companyTurning Point Therapeutics
HQ
San Diego, US
Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases.
View companyNATCO Pharma
HQ
Hyderabad, IN
Employees
4,016
NATCO Pharma is a company focused on research, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (API).
View company